Gottlieb Features Compounding in Farewell Congressional Testimony

Drug Industry Daily
A A
Outgoing FDA Commissioner Scott Gottlieb highlighted plans for drug compounding enforcement among the agency’s drug priorities in his final testimony before House appropriators on Wednesday.

To View This Article:

Login

Subscribe To Drug Industry Daily